Sunshine Biopharma Inc. 8-K Summary
Business Context and Reporting Period
Sunshine Biopharma Inc. (SBFM), a Colorado corporation, filed this Current Report on Form 8-K on April 17, 2024. The company is incorporated in Colorado and maintains its principal executive offices in New York, NY. Its common stock and warrants trade on The Nasdaq Stock Market LLC.
Key Financial Metrics
This filing is a current report regarding a corporate action and does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The filing text does not provide a clear value for any financial metrics.
Material Changes
Effective April 17, 2024, the Company filed a certificate of amendment to its articles of incorporation with the Secretary of State of Colorado. This amendment effects a 1-for-100 reverse split of the Company's common stock.
Guidance, Outlook, and Risks
The filing contains no management commentary, forward-looking guidance, risk factors, or discussion of contingencies beyond the execution of the reverse stock split. No unusual items were reported in this document.
Investor Verification Checklist
- Verify the post-split share count and adjusted trading price on Nasdaq.
- Confirm the treatment of outstanding Common Stock Purchase Warrants (SBFMW) following the 1-for-100 reverse split.
- Review the filed Certificate of Amendment (Exhibit 3.1) for specific terms of the stock split.
- Check subsequent filings for updated financial statements reflecting the capital structure change.